Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available

Martin P. Grobusch; Bradley A. Connor

doi:10.1016/j.tmaid.2022.102391

Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available

Martin P. Grobusch^*
, Bradley A. Connor

^*Corresponding author for this work

University of Tübingen
University of Cape Town
Centre de Recherches Médicales de Lambaréné
Masanga Medical Research Unit, Masanga, Tonkolili District, Sierra Leone
Cornell University
New York Center for Travel and Tropical Medicine, New York City, United States

Research output: Contribution to journal › Editorial › Academic › peer-review

17 Downloads (Pure)

Original language	English
Article number	102391
Journal	Travel medicine and infectious disease
Volume	49
DOIs	https://doi.org/10.1016/j.tmaid.2022.102391
Publication status	Published - 1 Sept 2022

Keywords

Arthritis
Chikungunya
Long-term sequelae
Severe disease
Vaccine

Access to Document

10.1016/j.tmaid.2022.102391

Factors-impacting-severe-disease-from-chikungunya-infection.pdfFinal published version, 377 KBLicence: CC BY

Cite this

@article{b9a89908e1064ee7bbbae3fcc9323221,

title = "Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available",

keywords = "Arthritis, Chikungunya, Long-term sequelae, Severe disease, Vaccine",

author = "Grobusch, \{Martin P.\} and Connor, \{Bradley A.\}",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.tmaid.2022.102391",

language = "English",

volume = "49",

journal = "Travel medicine and infectious disease",

issn = "1477-8939",

publisher = "Elsevier USA",

}

TY - JOUR

T1 - Factors impacting severe disease from chikungunya infection

T2 - Prioritizing chikungunya vaccine when available

AU - Grobusch, Martin P.

AU - Connor, Bradley A.

PY - 2022/9/1

Y1 - 2022/9/1

KW - Arthritis

KW - Chikungunya

KW - Long-term sequelae

KW - Severe disease

KW - Vaccine

UR - https://www.scopus.com/pages/publications/85133714314

U2 - 10.1016/j.tmaid.2022.102391

DO - 10.1016/j.tmaid.2022.102391

M3 - Editorial

C2 - 35752291

SN - 1477-8939

VL - 49

JO - Travel medicine and infectious disease

JF - Travel medicine and infectious disease

M1 - 102391

ER -

Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available

Keywords

Access to Document

Other files and links

Cite this